www.pharmatechoutlook.comE D I T IO NNOVEMBER - 20 - 2023$15ISSN 2644-2787Alexis Bossie,Head of Media R&D,LonzaPHARMA COMPLIANCEPOTENTIAL OF CELL AND GENE THERAPY
Page 2 >